We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$116B
AUM Growth
-$14.5B
Cap. Flow
-$18.4B
Cap. Flow %
-15.82%
Top 10 Hldgs %
26.94%
Holding
7,691
New
402
Increased
2,587
Reduced
3,614
Closed
585

Sector Composition

Rank Sector Weight
1 Technology 7.41%
2 Healthcare 5.88%
3 Financials 5.51%
4 Consumer Discretionary 4.79%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPCN icon
5651
Lipocine
LPCN
$17.6M
$41K ﹤0.01%
1,876
-477
-20% -$11.4K
MTG icon
5652
PUT
MGIC Investment
MTG
$6.35B
$41K ﹤0.01%
3,800
-57,900
-94% -$630K
RCUS icon
5653
Arcus Biosciences
RCUS
$3.62B
$41K ﹤0.01%
+3,255
New +$51.1K
RES icon
5654
PUT
RPC Inc
RES
$1.31B
$41K ﹤0.01%
2,800
+2,200
+367% +$37.6K
RYTM icon
5655
Rhythm Pharmaceuticals
RYTM
$7.26B
$41K ﹤0.01%
1,325
-2,843
-68% -$77.7K
VTI icon
5656
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$41K ﹤0.01%
292
-24,221
-99% -$3.38M
QTTB icon
5657
Q32 Bio
QTTB
$480M
$41K ﹤0.01%
+110
New +$39.4K
LGTY
5658
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$41K ﹤0.01%
2,820
-2,934
-51% -$39.6K
RETA
5659
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$41K ﹤0.01%
1,168
-3,048
-72% -$92.8K
DRNA
5660
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$41K ﹤0.01%
3,337
-38,253
-92% -$481K
OXFD
5661
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$41K ﹤0.01%
3,178
-2,097
-40% -$28.3K
KEYW
5662
DELISTED
The KEYW Holding Corporation
KEYW
$41K ﹤0.01%
4,678
-8,256
-64% -$69.2K
BSPM
5663
DELISTED
Biostar Pharmaceuticals, Inc.
BSPM
$41K ﹤0.01%
+18,300
New +$45.8K
BMRC icon
5664
Bank of Marin Bancorp
BMRC
$478M
$40K ﹤0.01%
996
-2,322
-70% -$88.8K
EQBK icon
5665
Equity Bancshares
EQBK
$1.06B
$40K ﹤0.01%
977
-1,275
-57% -$51.5K
FBK icon
5666
FB Financial Corp
FBK
$3.1B
$40K ﹤0.01%
973
-6,121
-86% -$253K
GERN icon
5667
Geron
GERN
$860M
$40K ﹤0.01%
11,663
-42,072
-78% -$161K
KE
5668
Kimball Electronics
KE
$653M
$40K ﹤0.01%
2,198
-5,606
-72% -$100K
LXU icon
5669
LSB Industries
LXU
$706M
$40K ﹤0.01%
9,872
-428
-4% -$1.83K
NIC icon
5670
Nicolet Bankshares
NIC
$3.67B
$40K ﹤0.01%
709
-1,324
-65% -$74.5K
SEB icon
5671
Seaboard Corp
SEB
$4.21B
$40K ﹤0.01%
10
-2
-17% -$8.07K
CUTR
5672
PUT
DELISTED
Cutera, Inc.
CUTR
$40K ﹤0.01%
1,000
+900
+900% +$41.5K
KA
5673
DELISTED
Kineta, Inc. Common Stock
KA
$40K ﹤0.01%
103
-290
-74% -$181K
CALA
5674
DELISTED
Calithera Biosciences, Inc
CALA
$40K ﹤0.01%
393
-548
-58% -$62.1K
ALTA
5675
DELISTED
Altabancorp
ALTA
$40K ﹤0.01%
1,124
-1,769
-61% -$60.7K

Similar funds

Barclays's Q2 2018 Portfolio in Review

As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,614 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.

By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in Evergy worth $42M.

  • Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
  • Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
  • Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
  • Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
  • Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
  • Barclays opened 402 new positions and closed 585 in Q2 2018.
  • Barclays's portfolio value fell 11% quarter-over-quarter to $116B.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.